Index | Ligand Name | Structure | PDB code | ligand desolvation |
1 | 4y6 | Identification of a Novel Allosteric Binding Site for RORgt Inhibitors | 5c4t | 99.87 |
2 | 4y5 | Identification of a Novel Allosteric Binding Site for RORgt Inhibitors | 5c4s | 99.78 |
3 | 4y7 | Identification of a Novel Allosteric Binding Site for RORgt Inhibitors | 5c4u | 99.78 |
4 | 39k | Crystal structure of RORc in complex with a tertiary sulfonamide inverse agonist | 4qm0 | 99.18 |
5 | 3sx | Crystal structure of RORc in complex with a benzyl sulfonamide inverse agonist | 4wqp | 98.84 |
6 | l7p | RORgamma Ligand Binding Domain | 6nwt | 98.4 |
7 | l8a | Crystal structure of RAR-related orphan receptor C in complex with a phenyl (3-phenylpyrrolidin-3-yl)sulfone inhibitor | 6o98 | 97.93 |
8 | 92a | X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an inverse agonist and SRC2 peptide | 5vb5 | 97.49 |
9 | vyi | Ligand complex of RORg LBD | 5aph | 97.31 |
10 | 98n | Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds | 5ntw | 96.53 |
11 | c3s | Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds | 5nti | 96.3 |
12 | 4cz | Crystal structure of RORgamma complexed with SRC2 and compound 5d | 5yp5 | 96.1 |
13 | 79u | Discovery of phenoxyindazoles and phenylthioindazoles as RORg inverse agonists | 5lwp | 96.04 |
14 | hc9 | Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand | 3l0j | 95.98 |
15 | hbw | Crystal structure of human ROR gamma LBD in complex with a quinoline sulfonamide inverse agonist | 6q2w | 95.96 |
16 | hc2 | Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand | 3kyt | 95.94 |
17 | f7j | RORC2 LBD complexed with compound 34 | 6cn6 | 95.82 |
18 | 927 | X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an inverse agonist and SRC2 peptide | 5vb6 | 95.81 |
19 | 3qq | Crystal structure of RORc in complex with a partial inverse agonist compound | 4wlb | 95.63 |
20 | f7m | HUMAN RETENOID-RELATED ORPHAN RECEPTOR-GAMMA LIGAND- BINDING DOMAIN IN COMPLEX WITH INDOLE LIGAND CP9b IN INVERSE AGONIST CONFORMATION | 6cn5 | 95.48 |
21 | 8y2 | Ligand complex of RORg LBD | 5ni8 | 95.44 |
22 | hc3 | Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand | 3l0l | 95.35 |
23 | 8y5 | Ligand complex of RORg LBD | 5nib | 95.3 |
24 | q6y | Synthesis and biological evaluation of new triazolo and imidazolopyridine RORgt inverse agonists | 5m96 | 95.29 |
25 | 921 | X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an agonist and SRC2 peptide | 5vb7 | 95.25 |
26 | nbh | Crystal structure of the orphan nuclear receptor ROR(gamma)t ligand-binding domain in complex with small molecule ligand | 4nie | 94.9 |
27 | b6l | Crystal Structure Analysis of the ROR gamma(C455E) | 6j1l | 94.62 |
28 | 98h | Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds | 5ntn | 94.53 |
29 | xgh | IDENTIFICATION OF BICYCLIC HEXAFLUOROISOPROPYL ALCOHOL SULFONAMIDES AS RORGT/RORC INVERSE AGONISTS | 6bn6 | 94.31 |
30 | cf7 | Structure of RORgt in complex with a novel inverse agonist 3 | 6b33 | 94.08 |
31 | l77 | RORgamma Ligand Binding Domain | 6nws | 93.94 |
32 | 98e | Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds | 5ntp | 93.85 |
33 | 76e | Ligand complex of RORg LBD | 5apk | 93.73 |
34 | hoj | Structure of RORgt in complex with a novel agonist. | 6e3g | 93.48 |
35 | zbd | X-ray co-structure of nuclear receptor ROR-GAMMAT + SRC2 peptide with a benzothiadiazole dioxide inverse agonist | 4ymq | 93.07 |
36 | 76e | Ligand complex of RORg LBD | 5apj | 92.59 |
37 | 6qp | Crystal structure of Retinoic acid receptor-related orphan receptor (ROR) gamma ligand binding domain complex with SBI0654919 | 5k6e | 92.44 |
38 | 4p1 | RORgamma in complex with inverse agonist 16 | 4zjw | 90.28 |
39 | 4q3 | RORgamma in complex with inverse agonist 4j. | 4zom | 90.08 |